华东医药：诚泽医药未经公司许可违规开展利拉鲁肽相关产品的市场推广活动

【华东医药：诚泽医药未经公司许可违规开展利拉鲁肽相关产品的市场推广活动】 华东医药股份有限公司微信公众号发布声明函称，全资子公司杭州中美华东制药有限公司与杭州诚泽医药有限公司于今年12月签署了关于利拉鲁肽（利鲁平）特定市场推广服务协议，委托诚泽医药在特定医疗机构进行利拉鲁肽注射液（利鲁平）预填充装和笔芯（以下简称“协议产品”）的市场推广服务。近日，诚泽医药违反协议约定，未经许可在苏州、杭州等地以“华东医药”名义违规开展协议产品的市场宣传和产品推广活动。","multimedia":{"img_url":["https://n.sinaimg.cn/zhibo/274/w617h457/20231218/37d4-21170903eba86a29d4dd2a973a2ed45d.png"]},"commentid":"live:finance-152-3414426:0","compere_id":0,"creator":"mingyu@staff.sina.com.cn","mender":"mingyu@staff.sina.com.cn","create_time":"2023-12-18 18:12:54","update_time":"2023-12-18 18:13:04","is_need_check":"1","check_time":"2023-12-18 18:12:58","check_status":"1","check_user":"mingyu@staff.sina.com.cn","is_delete":0,"top_value":0,"is_focus":0,"source_content_id":"0","anchor_image_url":"","anchor":"直播员","ext":"{"stocks":[{"market":"cn","symbol":"sz000963","key":"u534eu4e1cu533bu836f"},{"market":"fund","symbol":"159938","key":"u533bu836f"},{"market":"fund","symbol":"159891","key":"u533bu7597"}],"needPush":false,"needAIPush":false,"needCMSLink":true,"needCalender":false,"needProvince":"0","docurl":"https:\/\/finance.sina.com.cn\/7x24\/2023-12-18\/doc-imzymrzx3736630.shtml","docid":"mzymrzx3736630"}","old_live_cid":"0","tab":"","is_repeat":"0","tag":[{"id":"3","name":"公司"}],"like_nums":0,"comment_list":{"list":[],"total":0,"thread_show":0,"qreply":0,"qreply_show":0,"show":0},"docurl":"https://finance.sina.cn/7x24/2023-12-18/detail-imzymrzx3736630.d.html","rich_text_nick_to_url":[],"rich_text_nick_to_routeUri":[],"compere_info":""},{"id":3414424,"zhibo_id":152,"type":0,"rich_text":"新大正：总裁刘文波等5名董事、高管拟合计不低于1070万元增持公司股份。